NCT06588738Phase 3Completed

A Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Efficacy and Safety of ESK-001

Study sponsor: Alumis Inc · ALMS

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2025-09-23Actual
Enrollment · participants862Actual
Source updated2026-10-28Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 3 fields changed

Participant count type changed

Before: Estimated. After: Actual.

Enrollment · participant count changed

Before: 840 participants (planned). After: 862 participants (actual).

Recruitment status changed

Before: Active not recruiting. After: Completed.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview